BioSpace News Archive

Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease, today announced data demonstrating that genetic inhibition of SARM1 prevents axonal degeneration in the central, ocular and peripheral nervous systems.

“Politicians promise to lower costs and assure quality medical care, but voters need to beware,” states the Association of American Physicians and Surgeons (AAPS). Here are some common misconceptions about Medicare for All: Myth

NEW BEDFORD, Mass., /PRNewswire/ -- Registered nurses at St. Luke’s Hospital have filed notice with the National Labor Relations Board seeking an election to join the Massachusetts Nurses Association because they are seeking a strong voice in improving conditions for their patients and for the nurses who provide patients 24-hour a day care.